Cargando…
Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis
WEE2 oocyte meiosis inhibiting kinase is a well-conserved oocyte specific kinase with a dual regulatory role during meiosis. Active WEE2 maintains immature, germinal vesicle stage oocytes in prophase I arrest prior to the luteinizing hormone surge and facilitates exit from metaphase II arrest at fer...
Autores principales: | Hanna, Carol B, Mudaliar, Deepti, John, Kristen, Allen, C Leigh, Sun, Luxin, Hawkinson, Jon E, Schönbrunn, Ernst, Georg, Gunda I, Jensen, Jeffrey T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401407/ https://www.ncbi.nlm.nih.gov/pubmed/32667031 http://dx.doi.org/10.1093/biolre/ioaa097 |
Ejemplares similares
-
Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception(†)
por: Faber, Erik B, et al.
Publicado: (2020) -
Retinoic acid receptor antagonists for male contraception: current status(†)
por: Noman, Md Abdullah Al, et al.
Publicado: (2020) -
Systemic hormonal contraception and risk of venous thromboembolism
por: Heikinheimo, Oskari, et al.
Publicado: (2022) -
The Na(+) and K(+) transport system of sperm (ATP1A4) is essential for male fertility and an attractive target for male contraception
por: Syeda, Shameem Sultana, et al.
Publicado: (2020) -
Mechanism of semen liquefaction and its potential for a novel non-hormonal contraception(†)
por: Anamthathmakula, Prashanth, et al.
Publicado: (2020)